Anthem Blue Cross (HMO, PPO, EPO)
Portrazza (necitumumab)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: NSCLC EGFR Mutated:
    Duration: 1 year(s)

  • NSCLC EGFR Mutated:
    Duration: 1 year(s)
    Documented Diagnosis: No
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

  • Step Therapy: NSCLC EGFR Mutated:
    ST Multiple Generics

  • Available only through Specialty Pharmacy;